Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 1/20 | 0.54 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.54 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.54 |
| ▸ | GSR | P00390 | 1/20 | 0.48 |
| ▸ | TLR2 | O60603 | 2/20 | 0.48 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.48 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.47 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.47 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.47 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | RRM1 | P23921 | 1/20 | 0.41 |
| ▸ | DPP4 | P27487 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.40 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.40 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL722145 | 1.00 | GNAI3 (0.54) | GNAI3GNAO1GNAI1GSRTLR2 | |
| SCHEMBL14935740 | 1.00 | GNAI3 (0.54) | GNAI3GNAO1GNAI1GSRTLR2 | |
| Hydrochloric Acid SCHEMBL6428766 | 0.98 | GNAI3 (0.53) | GNAI3GNAO1GNAI1GSRTLR2 | |
| SCHEMBL856465 | 0.98 | GNAI3 (0.51) | GNAI3GNAO1GNAI1GSRTLR2 | |
| SCHEMBL2494020 | 0.98 | GNAI3 (0.51) | GNAI3GNAO1GNAI1GSRTLR2 | |
| Hydrochloric Acid SCHEMBL9537364 | 0.97 | GNAI3 (0.50) | GNAI3GNAO1GNAI1GSRTLR2 | |
| Hydrochloric Acid SCHEMBL10580924 | 0.97 | GNAI3 (0.50) | GNAI3GNAO1GNAI1GSRTLR2 | |
| SCHEMBL7771135 | 0.95 | GNAI3 (0.56) | GNAI3GNAO1GNAI1GSRTLR2 | |
| SCHEMBL5267100 | 0.95 | GNAI3 (0.56) | GNAI3GNAO1GNAI1GSRTLR2 | |
| SCHEMBL10614116 | 0.95 | GNAI3 (0.56) | GNAI3GNAO1GNAI1GSRTLR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014121819-A1 | FOLATE FUNCTIONALIZED NANODIAMOND PARTICLES, METHOD FOR ITS PREPARATION AND THEIR USE | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2014-08-14 | — | — | WO | claimed |
| US-12605464-B2 | Cyclohexane lipidoids for nucleic acid transfection and use thereof | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) | 2026-04-21 | — | — | US | disclosed |
| US-20240335559-A1 | CYCLOHEXANE LIPIDOIDS FOR NUCLEIC ACID TRANSFECTION AND USE THEREOF | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) | 2024-10-10 | — | — | US | disclosed |
| EP-4373804-A1 | CYCLOHEXANE LIPIDOIDS FOR NUCLEIC ACID TRANSFECTION AND USE THEREOF | Ustav Organicke Chemie a Biochemie AV CR v.v.i. (CZ) | 2024-05-29 | — | — | EP | disclosed |
| WO-2024089248-A1 | RECOMBINANT ACTIVATION-ASSOCIATED SECRETED PROTEIN | UNIVERSITEIT GENT (BE) | 2024-05-02 | — | — | WO | disclosed |
| WO-2023001323-A1 | CYCLOHEXANE LIPIDOIDS FOR NUCLEIC ACID TRANSFECTION AND USE THEREOF | Ustav Organicke Chemie A Biochemie AV CR v.v.i. (CZ) | 2023-01-26 | — | — | WO | disclosed |
| EP-4010368-A1 | ANTI-NAMPT ANTIBODIES AND USES THEREOF | Aqualung Therapeutics Corp. (US) | 2022-06-15 | — | — | EP | disclosed |
| EP-3920969-A1 | CONNEXIN 43 ANTIBODIES AND USE THEREOF | Alamab Therapeutics, Inc. (US) | 2021-12-15 | — | — | EP | disclosed |
| WO-2021134040-A2 | ENHANCING EXPRESSION OF LINE-1 ENCODED ORF2P FOR CANCER THERAPEUTICS | THE JOHNS HOPKINS UNIVERSITY (US) | 2021-07-01 | — | — | WO | disclosed |
| EP-3830123-A1 | ANTI-SIGLEC-5 ANTIBODIES AND METHODS OF USE THEREOF | Alector LLC (US) | 2021-06-09 | — | — | EP | disclosed |
| EP-1377830-A2 | ARRAYS FOR DETERMINING BINDING OF BIOMOLECULES | PEPSCAN SYSTEMS B.V. (NL) | 2004-01-07 | — | — | EP | disclosed |
| EP-0854915-A4 | CD23 PROCESSING ENZYME PREPARATION | SMITHKLINE BEECHAM CORP (US) | 2003-01-22 | — | — | EP | disclosed |
| WO-2002066984-A2 | ARRAYS FOR DETERMINING BINDING OF BIOMOLECULES | PEPSCAN SYSTEMS B.V. (NL) | 2002-08-29 | — | — | WO | disclosed |
| US-6232089-B1 | INHIBITED BY (4-(N-HYDROXYAMINO)-2-ISOBUTYL-3-(2-THIOPHENEMETHYL)-SUCCINYL) -PHENYLALANINE-N-METHYL AMIDE AND 1,10-PHENANTHROLINE | SMITHKLINE BEECHAM CORPORATION | 2001-05-15 | — | — | US | disclosed |
| EP-1097381-A1 | METHOD FOR MANUFACTURING A CARRIER FOR CHEMICAL OR BIOCHEMICAL ASSAYS | PEPSCAN SYSTEMS B.V. (NL) | 2001-05-09 | — | — | EP | disclosed |
| WO-2000005584-A1 | METHOD FOR MANUFACTURING A CARRIER FOR CHEMICAL OR BIOCHEMICAL ASSAYS | PEPSCAN SYSTEMS B.V. (NL) | 2000-02-03 | — | — | WO | disclosed |
| WO-2000005583-A1 | PREPARATION CARRIER AND METHOD FOR ITS MANUFACTURE | STICHTING DIENST LANDBOUWKUNDIG ONDERZOEK (NL) | 2000-02-03 | — | — | WO | disclosed |
| EP-0854915-A1 | CD23 PROCESSING ENZYME PREPARATION | SMITHKLINE BEECHAM CORPORATION (US) | 1998-07-29 | — | — | EP | disclosed |
| WO-1997013848-A1 | CD23 PROCESSING ENZYME PREPARATION | SMITHKLINE BEECHAM CORPORATION (US) | 1997-04-17 | — | — | WO | disclosed |
| WO-1996035686-A1 | TRYPTAMINE DERIVATIVES, PREPARATION THEREOF AND MEDICAMENTS CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1996-11-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240335559-A1 | CYCLOHEXANE LIPIDOIDS FOR NUCLEIC ACID TRANSFECTION AND USE THEREOF | SGMS2, NR1H3, SGMS1 | GNAI3 2026/4885GNAO1 1147/4885GNAI1 2762/4885 |
| US-12605464-B2 | Cyclohexane lipidoids for nucleic acid transfection and use thereof | NR1H2, NPC1, NR1H3 | GNAI3 2050/4885GNAO1 904/4885GNAI1 2131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.